In a GVHD model, IL-33/ST2 signaling in CD4+ cells promoted expansion and led to upregulation of Tbet while inhibiting IL-10 and Foxp3 expression which led to an exacerbation of GVHD severity (142, 143). This evidence concerns the gene IL33 and graft versus host disease.